ERYtech Pharma creates high value products for hematology and oncology markets in hospital (more than one €billion market potential).
The portfolio is diversified in terms of products and well-balanced in term of maturity:
-
Main projects are in partnering stage
-
The four products target huge markets
-
Graspa® builds a franchise in solid tumours
-
First sales are planned within two years
-
Innovative products match the clinicians’ expectations and the most recent therapeutics
